125 related articles for article (PubMed ID: 38912808)
1. Vaginal fungi are associated with treatment-induced shifts in the vaginal microbiota and with a distinct genital immune profile.
Armstrong E; Hemmerling A; Miller S; Huibner S; Kulikova M; Liu R; Crawford E; Castañeda GR; Coburn B; Cohen CR; Kaul R
Microbiol Spectr; 2024 Jun; ():e0350123. PubMed ID: 38912808
[TBL] [Abstract][Full Text] [Related]
2. Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial.
Armstrong E; Hemmerling A; Miller S; Burke KE; Newmann SJ; Morris SR; Reno H; Huibner S; Kulikova M; Nagelkerke N; Coburn B; Cohen CR; Kaul R
Lancet Microbe; 2022 Jun; 3(6):e435-e442. PubMed ID: 35659905
[TBL] [Abstract][Full Text] [Related]
3. Vaginal Lactobacillus crispatus persistence following application of a live biotherapeutic product: colonization phenotypes and genital immune impact.
Armstrong E; Hemmerling A; Miller S; Huibner S; Kulikova M; Crawford E; Castañeda GR; Coburn B; Cohen CR; Kaul R
Microbiome; 2024 Jun; 12(1):110. PubMed ID: 38907268
[TBL] [Abstract][Full Text] [Related]
4. Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilli.
Armstrong E; Hemmerling A; Miller S; Burke KE; Newmann SJ; Morris SR; Reno H; Huibner S; Kulikova M; Liu R; Crawford ED; Castañeda GR; Nagelkerke N; Coburn B; Cohen CR; Kaul R
J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35113809
[TBL] [Abstract][Full Text] [Related]
5. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
Front Immunol; 2021; 12():730986. PubMed ID: 34594336
[TBL] [Abstract][Full Text] [Related]
6. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
[TBL] [Abstract][Full Text] [Related]
7. Treatment Success Following Standard Antibiotic Treatment for Bacterial Vaginosis Is Not Associated With Pretreatment Genital Immune or Microbial Parameters.
Armstrong E; Hemmerling A; Joag V; Huibner S; Kulikova M; Crawford E; Castañeda GR; Anzala O; Obila O; Shahabi K; Ravel J; Coburn B; Cohen CR; Kaul R
Open Forum Infect Dis; 2023 Jan; 10(1):ofad007. PubMed ID: 36726539
[TBL] [Abstract][Full Text] [Related]
8. Response to Antibiotic Treatment of Bacterial Vaginosis Predicts the Effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the Prevention of Recurrent Disease.
Hemmerling A; Wierzbicki MR; Armstrong E; Cohen CR
Sex Transm Dis; 2024 Jun; 51(6):437-440. PubMed ID: 38733973
[TBL] [Abstract][Full Text] [Related]
9. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.
Ngugi BM; Hemmerling A; Bukusi EA; Kikuvi G; Gikunju J; Shiboski S; Fredricks DN; Cohen CR
Sex Transm Dis; 2011 Nov; 38(11):1020-7. PubMed ID: 21992977
[TBL] [Abstract][Full Text] [Related]
10. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
[TBL] [Abstract][Full Text] [Related]
11. Single-Molecule Approach to 16S rRNA for Vaginal Microbiome Signatures in Response to Metronidazole Treatment.
Qin H; Jiao J; A D; Hua M; Han K; Du H; Wang Z; Li J; Zhang D; Xiao B; Chen C
Microbiol Spectr; 2023 Jun; 11(3):e0170622. PubMed ID: 37199621
[TBL] [Abstract][Full Text] [Related]
12. Association of
Ardizzone CM; Taylor CM; Toh E; Lillis RA; Elnaggar JH; Lammons JW; Mott PD; Duffy EL; Shen L; Quayle AJ
Front Cell Infect Microbiol; 2023; 13():1289449. PubMed ID: 38149008
[TBL] [Abstract][Full Text] [Related]
13. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
Pramanick R; Mayadeo N; Warke H; Begum S; Aich P; Aranha C
Microb Pathog; 2019 Sep; 134():103599. PubMed ID: 31212037
[TBL] [Abstract][Full Text] [Related]
14. Optimizing the vaginal microbiome as a potential strategy to reduce heterosexual HIV transmission.
Armstrong E; Kaul R; Cohen CR
J Intern Med; 2023 Apr; 293(4):433-444. PubMed ID: 36544257
[TBL] [Abstract][Full Text] [Related]
15. Orally administrated
Qi F; Fan S; Fang C; Ge L; Lyu J; Huang Z; Zhao S; Zou Y; Huang L; Liu X; Liang Y; Zhang Y; Zhong Y; Zhang H; Xiao L; Zhang X
Front Immunol; 2023; 14():1125239. PubMed ID: 37575226
[TBL] [Abstract][Full Text] [Related]
16. Persistent, Asymptomatic Colonization with
Happel AU; Gasper M; Balle C; Konstantinus I; Gamieldien H; Dabee S; Gill K; Bekker LG; Passmore JS; Jaspan HB
Microbiol Spectr; 2022 Apr; 10(2):e0162621. PubMed ID: 35348351
[TBL] [Abstract][Full Text] [Related]
17. Host Genetic Factors Associated with Vaginal Microbiome Composition in Kenyan Women.
Mehta SD; Nannini DR; Otieno F; Green SJ; Agingu W; Landay A; Zheng Y; Hou L
mSystems; 2020 Jul; 5(4):. PubMed ID: 32723796
[TBL] [Abstract][Full Text] [Related]
18. Beyond bacterial vaginosis: vaginal lactobacilli and HIV risk.
Armstrong E; Kaul R
Microbiome; 2021 Dec; 9(1):239. PubMed ID: 34893070
[TBL] [Abstract][Full Text] [Related]
19. Characterization of vaginal fungal communities in healthy women and women with bacterial vaginosis (BV); a pilot study.
Lehtoranta L; Hibberd AA; Yeung N; Laitila A; Maukonen J; Ouwehand AC
Microb Pathog; 2021 Dec; 161(Pt A):105055. PubMed ID: 34146644
[TBL] [Abstract][Full Text] [Related]
20. Associations between the vaginal microbiome and Candida colonization in women of reproductive age.
Tortelli BA; Lewis WG; Allsworth JE; Member-Meneh N; Foster LR; Reno HE; Peipert JF; Fay JC; Lewis AL
Am J Obstet Gynecol; 2020 May; 222(5):471.e1-471.e9. PubMed ID: 31654610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
